Table 1.
Project title | Methodology area | Interviewee number* |
---|---|---|
Flexible parametric models | Statistical | 13 |
Missing data for prognostics | Statistical | 13 |
Multi-variable modelling, prognostic modelling | Statistical | 13 |
Modelling the association between patient characteristics and change over time in a disease measure | Statistical | 3 |
Combining multiple imputation and inverse probability weighting | Statistical | 3 |
New measure of the predictive ability for a survival model | Statistical | 7 |
Bias two-arm multi-stage trials | Statistical | 7 |
Analysis of resources for trials | Statistical | 8 |
Restricted mean survival time | Statistical | 4 |
Multi-arm multi-stage trial design | Statistical | 5, 10 |
Biomarkers | Statistical | 4 |
Comparing dynamic treatment regimens or monitoring strategies | Statistical | 11, 12 |
Estimating the effect of time-varying treatment or exposure on outcome | Statistical | 11, 12 |
Developing guidance for researchers on patient and public involvement in clinical research | Trial conduct | 2 |
Consumer involvement in MRC CTU studies | Trial conduct | 2 |
DAMOCLES (DAta MOnitoring Committees: Lessons, Ethics, Statistics) | Trial conduct | 5 |
Retention strategies for randomized trials | Trial conduct | 14 |
Central monitoring techniques to replace on-site monitoring | Trial conduct | 6 |
Risk-based monitoring of trials | Trial conduct | 9 |
Analysis of subgroup interactions in individual patient data meta-analysis | Meta-analysis | 1 |
Total | 20 | 14 |
*Interviewees 2, 3, 4, 5, 7, 11, 12 and 13 discussed more than one project. CTU, clinical trials unit; MRC, UK Medical Research Council.